Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split-Thickness Skin Graft Donor Sites

NCT01807650 is registered in ClinicalTrials.gov with Birken AG as lead sponsor.

NCT NCT01807650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split-Thickness Skin Graft Donor Sites
Lead sponsor
Birken AG
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
September 30, 2014
Enrollment
112 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

wounds